Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.
about
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing dataHIV-1 Genetic Variability and Clinical ImplicationsA template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapyAre subtype differences important in HIV drug resistance?Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.Low-abundance resistant mutations in HIV-1 subtype C antiretroviral therapy-naive individuals as revealed by pyrosequencing.Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance.Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.NRTI backbone in HIV treatment: will it remain relevant?Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
P2860
Q28483758-16D9525A-9718-4621-8CEE-171340A6E3E3Q30352010-E42B346B-210B-4935-A6B5-382CD419E30AQ33927293-395171EF-DC79-44A4-8781-2007DD98BEC2Q34764036-67F38D0E-4CBD-4B93-BE5E-8897D36EF8A3Q35260403-F72DEA5E-F2BE-46E3-8B39-3CDB451AF306Q36077418-6A26E322-D05F-4A70-BE60-41C09F12E2E2Q36593975-056995D3-4A7D-4642-A551-C847812F3543Q36693481-155A9A0A-7464-4CBA-AA65-65AB6694DE38Q37633109-DF268AAC-0B63-434B-858F-2A9A5BD17C8EQ37634044-339DD51E-B4DC-4E69-BC1D-539713E33ADFQ37734688-449E1020-817D-4B3B-AB7A-DA3580064E17Q37942538-C52851D5-101B-4600-AC1B-C6B1762A95D3Q38009758-5EA8DDEA-46AF-42F4-9AC9-AB5E81B555CAQ38262356-E7D5BA53-8E23-418A-AB32-C00AE80C5664Q39043026-F75207E6-B891-4C00-9400-ED9A4F5337A2Q39533858-51D52AF2-DB1F-4A29-9F76-CC37A316E163Q42255433-BE731206-E551-4089-BAAF-0AEE7C05E13DQ46160580-8222C72D-FB20-48CA-88A0-5B6F1D0DCA6EQ46307515-3C9F5E4F-2414-40E4-9414-FA0A3ED60E52
P2860
Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Factors affecting template usa ...... type C variants of HIV type-1.
@en
Factors affecting template usa ...... type C variants of HIV type-1.
@nl
type
label
Factors affecting template usa ...... type C variants of HIV type-1.
@en
Factors affecting template usa ...... type C variants of HIV type-1.
@nl
prefLabel
Factors affecting template usa ...... type C variants of HIV type-1.
@en
Factors affecting template usa ...... type C variants of HIV type-1.
@nl
P2093
P2860
P356
P1476
Factors affecting template usa ...... type C variants of HIV type-1.
@en
P2093
Bluma G Brenner
Cédric F Invernizzi
Dimitrios Coutsinos
Hongtao Xu
Mark A Wainberg
P2860
P304
P356
10.3851/IMP1443
P577
2010-01-05T00:00:00Z